Talonavicular and naviculocuneiform fusion for treatment of Müller-Weiss disease

Weilin YU,Zhongmin SHI
DOI: https://doi.org/10.3969/j.issn.1674-1439.2014.04-008
2014-01-01
Abstract:Background:Müller-Weiss disease is an uncommon condition of unclear etiology in feet. In the absence of a satisfactory re-sponse to conservative measures, surgery is advocated to correct the deformity and alleviate the pain. Objective:To evaluate the clinical outcome of the talonavicular and naviculocuneiform fusion for the Müller-Weiss disease. Methods:Between May 2008 and April 2012, 28 patients with Müller-Weiss disease were treated by talonavicular and na-viculocuneiform fusion and iliacbone autograft in our hospital. There were 2 males and 26 females with a mean age of 55.3 years (range from 44 to 65 years). According to the Maceira staging, 8 feet were graded as stageⅢ, 9 feet of stageⅣ, and 11 feet of stage Ⅴ. Ten feet were fixed with cannulated screw and staples and eighteen feet were fixed with cannulated screw and“X”shape locking plate. American Orthopaedic Foot and Ankle Society (AOFAS) midfoot score and visual ana-log score (VAS) were recorded before and after surgery. Results:The final follow-up was achieved in 26 patients, and mean follow-up period was 16.2 months (range from 9 to 24 months). All feet got solid fusion and the mean union time was 13.4 weeks (range from 12 to 16 weeks). No infection, ne-crosis of skin or implant breakage occurred. AOFAS midfoot score increased from 42.6±13.4 preoperatively to 88±12 at the last follow-up (P<0.05). VAS decreased from 6.2±2.4 preoperatively to 0.6±0.4 at the last follow-up (P<0.05). Conclusions:Talonavicular and naviculocuneiform fusion is an effective and reliable surgical treatment for mid-and end-stage of Müller-Weiss disease.
What problem does this paper attempt to address?